Exact Mass: 386.9662
Exact Mass Matches: 386.9662
Found 62 metabolites which its exact mass value is equals to given mass value 386.9662,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
benzylhydrochlorothiazide
2H-1,2,4-Benzothiadiazine-7-sulfonamide,6-chloro-3,4-dihydro-3-(phenylmethyl)-, 1,1-dioxide
C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic > C49185 - Thiazide Diuretic Same as: D01246
5'-Hydroxylornoxicam
6-Chloro-4-hydroxy-N-(5-hydroxypyridin-2-yl)-2-methyl-1,1-dioxo-2H-1λ⁶-thieno[2,3-e][1,2]thiazine-3-carboximidate
5-Hydroxylornoxicam is a metabolite of Tenoxicam. 5-hydroxylornoxicam belongs to the family of Thienothiazines. These are heterocyclic compounds containing a thiophene ring fused to a thiazine.
Dibromophakellin - CASMI2016 Category 1 - Challenge 1
Dibromophakellin - CASMI2016 Category 1 - Challenge 1
(E)-2-amino-4-[3-(4,5-dibromo-1H-pyrole-2-carboxamido)prop-1-enyl]-1H-imidazole|(E)-N-(3-(2-amino-1H-imidazol-4-yl)allyl)-4,5-dibromo-1H-pyrrole-2-carboxamide|Oroidin|oroidine
(E)-2-amino-4-[3-(4,5-dibromo-1H-pyrole-2-carboxamido)prop-1-enyl]-1H-imidazole|(E)-N-(3-(2-amino-1H-imidazol-4-yl)allyl)-4,5-dibromo-1H-pyrrole-2-carboxamide|Oroidin|oroidine
4,5-dibromo-pyrrole-2-carboxylic acid 4-(3-amino-propenyl)-1(3)H-imidazol-2-ylamide
4,5-dibromo-pyrrole-2-carboxylic acid 4-(3-amino-propenyl)-1(3)H-imidazol-2-ylamide
glutathioselenol
glutathioselenol
A glutathione derivative that is glutathione in which the hydrogen attached to the sulfur is replaced by a selenol group.
Dibromophakellin - CASMI2016 Category 1 - Challenge 6
Dibromophakellin - CASMI2016 Category 1 - Challenge 6
5-Hydroxylornoxicam
6-chloro-4-hydroxy-N-(5-hydroxypyridin-2-yl)-2-methyl-1,1-dioxo-2H-1$l^{6},5,2-thieno[2,3-e][1$l^{6},2]thiazine-3-carboxamide
Thiazolidine, 3-[(2,5-dichlorophenyl)sulfonyl]-2-(4-methylphenyl)- (9CI)
Thiazolidine, 3-[(2,5-dichlorophenyl)sulfonyl]-2-(4-methylphenyl)- (9CI)
Thiazolidine, 3-[(3,4-dichlorophenyl)sulfonyl]-2-(4-methylphenyl)- (9CI)
Thiazolidine, 3-[(3,4-dichlorophenyl)sulfonyl]-2-(4-methylphenyl)- (9CI)
6-BROMO-2-(2,4-DIMETHOXYPHENYL)QUINOLINE-4-CARBOXYLICACID
6-BROMO-2-(2,4-DIMETHOXYPHENYL)QUINOLINE-4-CARBOXYLICACID
3-BOC-2-(4-BROMO-PHENYL)-THIAZOLIDINE-4-CARBOXYLIC ACID
3-BOC-2-(4-BROMO-PHENYL)-THIAZOLIDINE-4-CARBOXYLIC ACID
3-Bromo-N,N-dipropyl-5-(trifluoromethyl)benzenesulfonamide
3-Bromo-N,N-dipropyl-5-(trifluoromethyl)benzenesulfonamide
2-CYANO-N-CYCLOPROPYL-N-((2-FLUORO-4-IODOPHENYL)CARBAMOYL)ACETAMIDE
2-CYANO-N-CYCLOPROPYL-N-((2-FLUORO-4-IODOPHENYL)CARBAMOYL)ACETAMIDE
6-amino-3-cyclopropyl-1-(2-fluoro-4-iodophenyl)pyrimidine-2,4(1H,3H)-dione
6-amino-3-cyclopropyl-1-(2-fluoro-4-iodophenyl)pyrimidine-2,4(1H,3H)-dione
ISOPROPYL (2-IODO-4-METHYL-5-(TRIFLUOROMETHYL)PHENYL)CARBAMATE
ISOPROPYL (2-IODO-4-METHYL-5-(TRIFLUOROMETHYL)PHENYL)CARBAMATE
Benzenesulfonylchloride, 4-[2-[(5-chloro-2-methoxybenzoyl)amino]ethyl]-
Benzenesulfonylchloride, 4-[2-[(5-chloro-2-methoxybenzoyl)amino]ethyl]-
tert-butyl 2-amino-5-iodo-4-(trifluoromethyl)benzoate
tert-butyl 2-amino-5-iodo-4-(trifluoromethyl)benzoate
O-[3-chloro-4-(diethylsulfamoyl)phenyl] O,O-dimethyl phosphorothioate
O-[3-chloro-4-(diethylsulfamoyl)phenyl] O,O-dimethyl phosphorothioate
(4-chlorophenyl)-(3-methyl-1,3-benzothiazol-3-ium-2-yl)diazene,perchlorate
(4-chlorophenyl)-(3-methyl-1,3-benzothiazol-3-ium-2-yl)diazene,perchlorate
Bromotris(dimethylamino)phosphonium hexafluorophosphate
Bromotris(dimethylamino)phosphonium hexafluorophosphate
3-Bromo-N-hexyl-5-(trifluoromethyl)benzenesulfonamide
3-Bromo-N-hexyl-5-(trifluoromethyl)benzenesulfonamide
5-{[(4-Amino-3-Chloro-5-Fluorophenyl)sulfonyl]amino}-1,3,4-Thiadiazole-2-Sulfonamide
5-{[(4-Amino-3-Chloro-5-Fluorophenyl)sulfonyl]amino}-1,3,4-Thiadiazole-2-Sulfonamide
(-)-Dibromophakellin
(-)-Dibromophakellin
An alkaloid isolated from the marine sponge Phakellia flabellata and Acanthella costata. It acts as an alpha2B adrenoceptor agonist. D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists
2-[(2,4-dichlorophenoxy)acetyl]-N-(4-fluorophenyl)hydrazinecarbothioamide
2-[(2,4-dichlorophenoxy)acetyl]-N-(4-fluorophenyl)hydrazinecarbothioamide
1-[[(5-Bromo-2-furanyl)-oxomethyl]amino]-3-[(4-chlorophenyl)methyl]thiourea
1-[[(5-Bromo-2-furanyl)-oxomethyl]amino]-3-[(4-chlorophenyl)methyl]thiourea
ERK5-IN-2
ERK5-IN-2
ERK5-IN-2 is an orally active, sub-micromolar, selective ERK5 inhibitor with IC50s of 0.82 μM, 3 μM for ERK5 and ERK5 MEF2D, respectively. ERK5-IN-2 does not interact with the BRD4 bromodomain. ERK5-IN-2 suppresses both tumor xenograft growth and basic fibroblast growth factor (bFGF) driven Matrigel plug angiogenesis[1].
7,8-dibromo-3-imino-2,4,6,12-tetraazatetracyclo[10.3.0.0¹,⁵.0⁶,¹⁰]pentadeca-7,9-dien-11-one
7,8-dibromo-3-imino-2,4,6,12-tetraazatetracyclo[10.3.0.0¹,⁵.0⁶,¹⁰]pentadeca-7,9-dien-11-one
(1r,5s)-7,8-dibromo-3-imino-2,4,9,12-tetraazatetracyclo[10.3.0.0¹,⁵.0⁶,¹⁰]pentadeca-6(10),7-dien-11-one
(1r,5s)-7,8-dibromo-3-imino-2,4,9,12-tetraazatetracyclo[10.3.0.0¹,⁵.0⁶,¹⁰]pentadeca-6(10),7-dien-11-one
(1r,5s)-7,8-dibromo-3-imino-2,4,6,12-tetraazatetracyclo[10.3.0.0¹,⁵.0⁶,¹⁰]pentadeca-7,9-dien-11-one
(1r,5s)-7,8-dibromo-3-imino-2,4,6,12-tetraazatetracyclo[10.3.0.0¹,⁵.0⁶,¹⁰]pentadeca-7,9-dien-11-one
2,3-dibromo-4-(2-imino-1,3-dihydroimidazol-4-yl)-1h,4h,5h,6h,7h-pyrrolo[2,3-c]azepin-8-one
2,3-dibromo-4-(2-imino-1,3-dihydroimidazol-4-yl)-1h,4h,5h,6h,7h-pyrrolo[2,3-c]azepin-8-one
7,8-dibromo-3-imino-2,4,9,12-tetraazatetracyclo[10.3.0.0¹,⁵.0⁶,¹⁰]pentadeca-6(10),7-dien-11-one
7,8-dibromo-3-imino-2,4,9,12-tetraazatetracyclo[10.3.0.0¹,⁵.0⁶,¹⁰]pentadeca-6(10),7-dien-11-one
8,9-dibromo-3-imino-2,4,7,12-tetraazatetracyclo[10.3.0.0¹,⁵.0⁶,¹⁰]pentadeca-6(10),8-dien-11-one
8,9-dibromo-3-imino-2,4,7,12-tetraazatetracyclo[10.3.0.0¹,⁵.0⁶,¹⁰]pentadeca-6(10),8-dien-11-one
(1r,5r)-7,8-dibromo-3-imino-2,4,6,12-tetraazatetracyclo[10.3.0.0¹,⁵.0⁶,¹⁰]pentadeca-7,9-dien-11-one
(1r,5r)-7,8-dibromo-3-imino-2,4,6,12-tetraazatetracyclo[10.3.0.0¹,⁵.0⁶,¹⁰]pentadeca-7,9-dien-11-one
4,5-dibromo-n-[3-(2-imino-1,3-dihydroimidazol-4-yl)prop-2-en-1-yl]-1h-pyrrole-2-carboxamide
4,5-dibromo-n-[3-(2-imino-1,3-dihydroimidazol-4-yl)prop-2-en-1-yl]-1h-pyrrole-2-carboxamide
6,7-dibromo-4-[(2-imino-1,3-dihydroimidazol-4-yl)methyl]-2h,3h,4h-pyrrolo[1,2-a]pyrazin-1-one
6,7-dibromo-4-[(2-imino-1,3-dihydroimidazol-4-yl)methyl]-2h,3h,4h-pyrrolo[1,2-a]pyrazin-1-one
(1s,5r)-8,9-dibromo-3-imino-2,4,7,12-tetraazatetracyclo[10.3.0.0¹,⁵.0⁶,¹⁰]pentadeca-6(10),8-dien-11-one
(1s,5r)-8,9-dibromo-3-imino-2,4,7,12-tetraazatetracyclo[10.3.0.0¹,⁵.0⁶,¹⁰]pentadeca-6(10),8-dien-11-one
(1r,5r)-7,8-dibromo-3-imino-2,4,9,12-tetraazatetracyclo[10.3.0.0¹,⁵.0⁶,¹⁰]pentadeca-6(10),7-dien-11-one
(1r,5r)-7,8-dibromo-3-imino-2,4,9,12-tetraazatetracyclo[10.3.0.0¹,⁵.0⁶,¹⁰]pentadeca-6(10),7-dien-11-one
(5r)-7,8-dibromo-3-imino-2,4,6,12-tetraazatetracyclo[10.3.0.0¹,⁵.0⁶,¹⁰]pentadeca-7,9-dien-11-one
(5r)-7,8-dibromo-3-imino-2,4,6,12-tetraazatetracyclo[10.3.0.0¹,⁵.0⁶,¹⁰]pentadeca-7,9-dien-11-one
n-{2,3-dibromo-9-oxo-1h,5h,6h,7h-pyrrolo[2,3-f]indolizin-4-yl}guanidine
n-{2,3-dibromo-9-oxo-1h,5h,6h,7h-pyrrolo[2,3-f]indolizin-4-yl}guanidine
(1s,5r)-7,8-dibromo-3-imino-2,4,6,12-tetraazatetracyclo[10.3.0.0¹,⁵.0⁶,¹⁰]pentadeca-7,9-dien-11-one
(1s,5r)-7,8-dibromo-3-imino-2,4,6,12-tetraazatetracyclo[10.3.0.0¹,⁵.0⁶,¹⁰]pentadeca-7,9-dien-11-one
(4s)-6,7-dibromo-4-[(2-imino-1,3-dihydroimidazol-4-yl)methyl]-2h,3h,4h-pyrrolo[1,2-a]pyrazin-1-one
(4s)-6,7-dibromo-4-[(2-imino-1,3-dihydroimidazol-4-yl)methyl]-2h,3h,4h-pyrrolo[1,2-a]pyrazin-1-one
(4r)-2,3-dibromo-4-(2-imino-1,3-dihydroimidazol-4-yl)-1h,4h,5h,6h,7h-pyrrolo[2,3-c]azepin-8-one
(4r)-2,3-dibromo-4-(2-imino-1,3-dihydroimidazol-4-yl)-1h,4h,5h,6h,7h-pyrrolo[2,3-c]azepin-8-one
(1s,5r)-7,8-dibromo-3-imino-2,4,9,12-tetraazatetracyclo[10.3.0.0¹,⁵.0⁶,¹⁰]pentadeca-6(10),7-dien-11-one
(1s,5r)-7,8-dibromo-3-imino-2,4,9,12-tetraazatetracyclo[10.3.0.0¹,⁵.0⁶,¹⁰]pentadeca-6(10),7-dien-11-one
